131 related articles for article (PubMed ID: 6134622)
1. Pharmacokinetics of oxmetidine, a new histamine H2-receptor antagonist, after single oral and intravenous doses.
Jönsson KA; Bodemar G; Gotthard R; Norlander B; Walan A
Eur J Clin Pharmacol; 1983; 24(3):353-6. PubMed ID: 6134622
[TBL] [Abstract][Full Text] [Related]
2. Gastric acid inhibition and oxmetidine kinetics in duodenal ulcer.
Gugler R; Rohner HG; Somogyi AA
Clin Pharmacol Ther; 1982 Apr; 31(4):501-8. PubMed ID: 6120776
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of CM 57755, a new histamine H2-receptor antagonist, after single oral doses in man.
Necciari J; Mery D; Garriot P; Escourrou J; Cautreels W
Int J Clin Pharmacol Res; 1985; 5(6):457-65. PubMed ID: 2869002
[TBL] [Abstract][Full Text] [Related]
4. Oxmetidine (SK&F 92994): pharmacokinetic study in patients with in patients with liver cirrhosis.
Miglio F; Baraldini M; Serra S; Facchini A; Stefanini GF; Meliconi R; Gasbarrini G; Labo' G
Int J Clin Pharmacol Res; 1985; 5(6):399-404. PubMed ID: 2869000
[TBL] [Abstract][Full Text] [Related]
5. Ranitidine: single dose pharmacokinetics and absolute bioavailability in man.
van Hecken AM; Tjandramaga TB; Mullie A; Verbesselt R; de Schepper PJ
Br J Clin Pharmacol; 1982 Aug; 14(2):195-200. PubMed ID: 6125204
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of the H2- receptor antagonist ranitidine in man.
McNeil JJ; Mihaly GW; Anderson A; Marshall AW; Smallwood RA; Louis WJ
Br J Clin Pharmacol; 1981 Sep; 12(3):411-5. PubMed ID: 6117305
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of piroximone (MDL 19.205) in healthy volunteers.
Haegele KD; Belz GG; Meinicke TT; Schechter PJ
Eur J Clin Pharmacol; 1986; 31(2):239-42. PubMed ID: 3803422
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of dexloxiglumide after administration of single and repeat oral escalating doses in healthy young males.
Persiani S; D'Amato M; Makovec F; Tavares IA; Bishai PM; Rovati LC
Int J Clin Pharmacol Ther; 2002 May; 40(5):198-206. PubMed ID: 12051571
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics in man of a new antiarrhythmic drug, cibenzoline.
Canal M; Flouvat B; Tremblay D; Dufour A
Eur J Clin Pharmacol; 1983; 24(4):509-15. PubMed ID: 6861865
[TBL] [Abstract][Full Text] [Related]
10. Famotidine pharmacokinetics following oral and intravenous administration in patients with liver disease: results of a preliminary study.
Morgan MY; Stambuk D
Postgrad Med J; 1986; 62 Suppl 2():29-37. PubMed ID: 2890149
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of oral and intravenous omeprazole in patients with the Zollinger-Ellison syndrome.
Vinayek R; Amantea MA; Maton PN; Frucht H; Gardner JD; Jensen RT
Gastroenterology; 1991 Jul; 101(1):138-47. PubMed ID: 2044903
[TBL] [Abstract][Full Text] [Related]
12. The pharmacokinetics of intravenous and oral sulpiride in healthy human subjects.
Wiesel FA; Alfredsson G; Ehrnebo M; Sedvall G
Eur J Clin Pharmacol; 1980 May; 17(5):385-91. PubMed ID: 7418717
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetic and pharmacodynamic properties of histamine H2-receptor antagonists. Relationship between intrinsic potency and effective plasma concentrations.
Lin JH
Clin Pharmacokinet; 1991 Mar; 20(3):218-36. PubMed ID: 1673880
[TBL] [Abstract][Full Text] [Related]
14. Effects of cirrhosis and ageing on the elimination and bioavailability of ranitidine.
Young CJ; Daneshmend TK; Roberts CJ
Gut; 1982 Oct; 23(10):819-23. PubMed ID: 6126422
[TBL] [Abstract][Full Text] [Related]
15. Safety and pharmacokinetics of mifentidine after increasing oral doses in healthy subjects.
Imbimbo BP; Seiberling M; Peuckert U; Hoexter G; Maier-Lenz H; Vidi A; Daniotti S
Eur J Clin Pharmacol; 1988; 35(6):673-6. PubMed ID: 2906876
[TBL] [Abstract][Full Text] [Related]
16. The metabolism in animals and man of oxmetidine--a new histamine H2-receptor antagonist.
Cox PJ; Heijbroek WM; Taylor DC; Wood PJ; Cresswell PR; Pepper ES; Moore PJ; Mitchell RC; Blake TJ; Dawborne JS
Xenobiotica; 1984 Jul; 14(7):509-14. PubMed ID: 6150580
[TBL] [Abstract][Full Text] [Related]
17. Kinetics of fenoximone, a new cardiotonic, in healthy subjects.
Alken RG; Belz GG; Haegele KD; Meinicke T; Schechter PJ
Clin Pharmacol Ther; 1984 Aug; 36(2):209-16. PubMed ID: 6235081
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of azapropazone following single oral and intravenous doses.
Breuing KH; Gilfrich HJ; Meinertz T; Jähnchen E
Arzneimittelforschung; 1979; 29(6):971-2. PubMed ID: 582795
[TBL] [Abstract][Full Text] [Related]
19. Single-dose pharmacokinetics and bioavailability of famotidine in man. Results of multicenter collaborative studies.
Yeh KC; Chremos AN; Lin JH; Constanzer ML; Kanovsky SM; Hucker HB; Antonello J; Vlasses P; Ryan JR; Williams RL
Biopharm Drug Dispos; 1987; 8(6):549-60. PubMed ID: 2892544
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of famotidine in man.
Kroemer H; Klotz U
Int J Clin Pharmacol Ther Toxicol; 1987 Aug; 25(8):458-63. PubMed ID: 2888738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
